Catalysts for $LBRX

LB PHARMACEUTICALS INC earnings

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Granules Pharmaceuticals Inc. recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Glenmark Pharmaceuticals Inc., USA recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls III)

Glenmark Pharmaceuticals Inc., USA recall (Cls III)

Lupin Pharmaceuticals Inc. recall (Cls II)

Lupin Pharmaceuticals Inc. recall (Cls II)

Glenmark Pharmaceuticals Inc., USA recall (Cls III)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

ENOBY (DENOSUMAB-QBDE) — FDA approval

Glenmark Pharmaceuticals Inc., USA recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Granules Pharmaceuticals Inc. recall (Cls III)

Granules Pharmaceuticals Inc. recall (Cls III)

Granules Pharmaceuticals Inc. recall (Cls III)

Granules Pharmaceuticals Inc. recall (Cls III)

Granules Pharmaceuticals Inc. recall (Cls III)

Glenmark Pharmaceuticals Inc., USA recall (Cls II)

ENOBY (DENOSUMAB-QBDE) — FDA approval

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)

Zydus Pharmaceuticals (USA) Inc recall (Cls II)